Clinical Trial Update: A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating ABT-652 versus placebo in painful diabetic neuropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Painful Diabetic Neuropathy

Drugs mentioned

• ABT-652

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Diabetic Neuropathic Pain | Phase 2 | Status: TERMINATED